Vestal Point Capital, LP Alector, Inc. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Alector, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 504,540 shares of ALEC stock, worth $560,039. This represents 0.04% of its overall portfolio holdings.
Number of Shares
504,540Holding current value
$560,039% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ALEC
# of Institutions
148Shares Held
55.2MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$10.8 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$10.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$6.72 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$2.18 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$1.82 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $91.6M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...